NV-CoV-2-R

N/A

Report date: 2023/05/17 08:51:32

Base Information

Drug NameNV-CoV-2-R
Drug Alias NameNV-CoV-2-R
ClassificationSmall molecules
Mechanisms of ActionVirus internalization inhibitorsBacterial DNA-directed RNA polymerase inhibitors
TargetsBacterial DNA-directed RNA polymerase
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNanoviricides
China Registration ClassN/A

Develop Information

Active CompaniesKarveer Meditech Pvt LtdNanoViricides IncNanoviricides
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A